We have located links that may give you full text access.
Bt Resistance Implications for Helicoverpa zea (Lepidoptera: Noctuidae) Insecticide Resistance Management in the United States.
Environmental Entomology 2018 October 3
Both maize and cotton genetically engineered to express Bt toxins are widely planted and important pest management tools in the United States. Recently, Helicoverpa zea (Boddie) (Lepidoptera: Noctuidae) has developed resistance to two toxin Bt maize and cotton (Cry1A and Cry2A). Hence, growers are transitioning to three toxin Bt cotton and maize that express both Cry toxins and the Vip3Aa toxin. H. zea susceptibility to Vip3Aa is threatened by 1) a lack of availability of non-Bt refuge crop hosts, including a 1-5% annual decline in the number of non-Bt maize hybrids being marketed; 2) the ineffectiveness of three toxin cultivars to function as pyramids in some regions, with resistance to two out of three toxins in the pyramid; and 3) the lack of a high dose Vip3Aa event in cotton and maize. We propose that data should be collected on current Cry-resistant H. zea in the field to inform future Bt resistance models and that the deployment of Bt toxins and non-Bt refuge crops should be adjusted to favor susceptibility of H. zea to Bt toxins such as Vip3Aa. Finally, maize growers should be incentivized to plant non-Bt structured refuge and have access to hybrids with high-yielding genetic potential at a reasonable price.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app